Sources | Names Used |
---|---|
CTRPv2 | selumetinib:vorinostat (8:1 mol/mol) |
PharmacoGx | selumetinib:vorinostat (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UPRT | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | MORC3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | ARMCX2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | CD302 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | BACE2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | RILP | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | RAD1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
mRNA | PLEKHA7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | SLC18B1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | COL16A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |